Patni Rajiv bought BTAI
January 9, 2026 · Form 4 insider transaction
Patni Rajiv bought 17,000 shares of BioXcel Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
17,000
Price
$0.00
Total value
N/A
InsiderPatni Rajiv
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 9, 2026
Filing dateJanuary 12, 2026
Shares owned after17,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date.